3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
41
Ovarian Neoplasms
4
Neoplasms
4
Neoplasm Metastasis
4
Squamous Cell Carcinoma of Head and Neck
3
Lymphoma
3
Breast Diseases
3
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Neoplasms by Site
2
Medulloblastoma
2
Lymphoma, Mantle-Cell
2
Liposarcoma
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Renal Cell
2
Breast Neoplasm Female
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Venous Thromboembolism
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Thyroid Neoplasms
1
Interventions
palbociclib
1
Gonadotropin-Releasing Hormone
1
Anastrozole
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Skin Diseases
×
palbociclib
×
Clear all
NCT04711252
2025-10-14
SERENA-4
AstraZeneca
Phase 3
Active not recruiting
1,370 enrolled